HK Asia Heart Centre
Latest round
- Series D
Last raised
- Feb 2022
Total raised
- $400M
Investors
- 10
About HK Asia Heart Centre
Established in 1999 and based in Hongkong, China, HK Asia Heart Centre operates as a cardiovascular specialty chain group that provides cardiac care services for patients. The company has two departments, named Cardiac Centre and Cardiac Catheterization & Intervention Laboratory (CCIL). The Cardiac Centre provides cardiac health check-up and cardiac consultation service. Its electrocardiogram (ECG) products can assist in diagnosing cardiac arrhythmias. By using ECG machine, the change of every heart activity can be recorded. The Cardiac Catheterization & Intervention Laboratory (CCIL) is equipped with biplane angiography system and auxiliary medical equipment, to facilitate invasive cardiovascular diagnostic service and treatment. It also provides 24 hours emergency interventional service for acute myocardial infarction patients.
Who invested in HK Asia Heart Centre
10 investors across 1 round
See all investors in HK Asia Heart Centre
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Feb 10, 2022
Amount
$400M
Investors
Questions about HK Asia Heart Centre
Who invested in HK Asia Heart Centre?
HK Asia Heart Centre has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HK Asia Heart Centre raised?
HK Asia Heart Centre has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did HK Asia Heart Centre last raise money?
HK Asia Heart Centre's most recent round on record is a Series D, in Feb 2022.
What does HK Asia Heart Centre do?
Established in 1999 and based in Hongkong, China, HK Asia Heart Centre operates as a cardiovascular specialty chain group that provides cardiac care services for patients.
Where is HK Asia Heart Centre headquartered?
HK Asia Heart Centre is headquartered in Hong Kong, China.
Which VCs invest in companies like HK Asia Heart Centre?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at HK Asia Heart Centre's stage. Their profiles are linked below.
VCs backing healthcare startups at Series D
Raising like HK Asia Heart Centre? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.